Rare Disease Genetic Testing Market Share

Statistics for the 2023 & 2024 Rare Disease Genetic Testing market share, created by Mordor Intelligence™ Industry Reports. Rare Disease Genetic Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Genetic Testing Research Rare Diseases Industry Market Share

Market Share of Rare Disease Genetic Testing Industry

The rare disease genetic testing market is highly competitive and fragmented due to the presence of many players. These players are present globally and regionally, which include Quest Diagnostics Incorporated, Eurofins Scientific Inc., SAmbry Genetics Corporations, PerkinElmer Genetics Inc., Baylor Miraca Genetics Laboratories LLC, and Beijing Genomics Institute Ltd.

Rare Disease Genetic Testing Market Leaders

  1. Quest Diagnostics Incorporated

  2. Invitae Corporation

  3. 3billion Inc.

  4. Eurofins Scientific, Inc.

  5. Centogene N.V.

*Disclaimer: Major Players sorted in no particular order

Rare Disease Genetic Testing Market Concentration

Rare Disease Genetic Testing Market Report Snapshots

Rare Disease Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)